|
End-of-day quote
HANOI S.E.
04/09/2026
|
5-day change | 1st Jan Change | ||
| 55,800.00 VND | +0.18% |
|
-1.41% | -20.29% |
| Market Cap | 5,054B 192M 167M 157M 142M 268M 18.33B 268M 1.85B 718M 9.4B 728M 713M 30.3B | P/E 2024 |
109x | P/E 2025 | 109x |
|---|---|---|---|---|---|
| Enterprise Value | 5,153B 196M 170M 160M 144M 273M 18.68B 273M 1.89B 732M 9.58B 742M 727M 30.89B | EV / Sales 2024 |
3.89x | EV / Sales 2025 | 2.68x |
| Free-Float |
25% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.18% | ||
| 1 week | -1.41% | ||
| Current month | -1.41% | ||
| 1 month | -6.22% | ||
| 3 months | -15.07% | ||
| 6 months | -19.36% | ||
| Current year | -20.29% |
| 1 week | 54,800 | 56,000 | |
| 1 month | 54,400 | 61,000 | |
| Current year | 54,400 | 75,800 | |
| 1 year | 54,400 | 86,800 | |
| 3 years | 17,090.91 | 100,818.18 | |
| 5 years | 11,980.52 | 100,818.18 | |
| 10 years | 4,801.26 | 100,818.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thang Xuan Le
CEO | Chief Executive Officer | 53 | 31/03/2016 |
Linh Viet Le
PRN | Corporate Officer/Principal | - | 29/02/2016 |
Trung Anh Le
PRN | Corporate Officer/Principal | 49 | 03/02/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Lo Van Le
CHM | Chairman | 75 | 31/12/2015 |
Thang Xuan Le
BRD | Director/Board Member | 53 | - |
Tue Van Hoang
BRD | Director/Board Member | 62 | 31/05/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.18% | -1.41% | -29.12% | +165.71% | 194M | ||
| -0.88% | -2.15% | +58.05% | +105.91% | 1,024B | ||
| -1.15% | +2.68% | +54.25% | +71.29% | 663B | ||
| -1.44% | +0.38% | +20.65% | +75.54% | 453B | ||
| +0.14% | -0.47% | +30.20% | +40.61% | 352B | ||
| -1.33% | +4.72% | +24.62% | +47.60% | 304B | ||
| -1.15% | +0.30% | -0.69% | +11.83% | 252B | ||
| -1.55% | +1.11% | +54.15% | +72.13% | 236B | ||
| -0.88% | +1.15% | -14.60% | -54.84% | 206B | ||
| -0.15% | +3.65% | +31.24% | +100.90% | 187B | ||
| Average | -0.82% | +0.74% | +22.87% | +63.67% | 367.86B | |
| Weighted average by Cap. | -0.96% | +0.55% | +37.63% | +67.01% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2,086B 79.28M 68.85M 64.68M 58.42M 111M 7.57B 111M 766M 296M 3.88B 300M 294M 12.51B | 2,402B 91.28M 79.27M 74.46M 67.26M 127M 8.71B 127M 882M 341M 4.47B 346M 339M 14.4B |
| Net income | 71.77B 2.73M 2.37M 2.22M 2.01M 3.8M 260M 3.8M 26.34M 10.19M 133M 10.34M 10.12M 430M | 53.66B 2.04M 1.77M 1.66M 1.5M 2.84M 195M 2.84M 19.69M 7.62M 99.75M 7.73M 7.57M 322M |
| Net Debt | 290B 11.02M 9.57M 8.99M 8.12M 15.37M 1.05B 15.37M 106M 41.17M 539M 41.75M 40.88M 1.74B | 98.73B 3.75M 3.26M 3.06M 2.76M 5.23M 358M 5.23M 36.23M 14.02M 184M 14.22M 13.92M 592M |
Employees
586
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | ₫55,800.00 | +0.18% | 7,707 |
| 03/09/26 | ₫55,700.00 | -1.59% | 510 |
- Stock Market
- Stocks
- DHT Stock
Select your edition
All financial news and data tailored to specific country editions
















